The Coronary Drug Project Research Group, 1975, JAMA, 231, 360, 10.1001/jama.1975.03240160024021
1978, Br Heart J, 40, 1069, 10.1136/hrt.40.10.1069
Frick, 1987, N Engl J Med, 317, 1237, 10.1056/NEJM198711123172001
Brown, 1986, Arteriosclerosis, 6, 670, 10.1161/01.ATV.6.6.670
Kesäniemi, 1984, J Lipid Res, 25, 780, 10.1016/S0022-2275(20)37741-5
Kita, 1987, Proc Natl Acad Sci USA, 84, 5928, 10.1073/pnas.84.16.5928
The Expert Panel, 1988, Arch Intern Med, 148, 36, 10.1001/archinte.1988.00380010040006
Grundy, 1977, J Lab Clin Med, 89, 354
Kane, 1981, N Engl J Med, 304, 251, 10.1056/NEJM198101293040502
Blankenhom, 1987, JAMA, 257, 3233, 10.1001/jama.1987.03390230069027
Canner, 1986, J Am Coll Cardiol, 8, 1245, 10.1016/S0735-1097(86)80293-5
1984, JAMA, 251, 351, 10.1001/jama.1984.03340270029025
1984, JAMA, 251, 365, 10.1001/jama.1984.03340270043026
1985, JAMA, 253, 2080, 10.1001/jama.1985.03350380096029
Levy, 1984, Circulation, 69, 325, 10.1161/01.CIR.69.2.325
Endo, 1976, J Antibiot (Tokyo), 29, 1346, 10.7164/antibiotics.29.1346
Endo, 1976, FEBS Lett, 72, 323, 10.1016/0014-5793(76)80996-9
Tsujita, 1979, Atherosclerosis, 32, 307, 10.1016/0021-9150(79)90174-6
Shigematsu, 1979, Geriatr Med (Japan), 17, 1564
Yamamoto, 1980, Atherosclerosis, 35, 259, 10.1016/0021-9150(80)90124-0
Mabuchi, 1981, N Engl J Med, 305, 478, 10.1056/NEJM198108273050902
Alberts, 1980, Proc Natl Acad Sci USA, 77, 3957, 10.1073/pnas.77.7.3957
Tobert, 1982, J Clin Invest, 69, 913, 10.1172/JCI110530
Kovanen, 1981, Proc Natl Acad Sci USA, 78, 1194, 10.1073/pnas.78.2.1194
Bilheimer, 1983, Proc Natl Acad Sci USA, 80, 4124, 10.1073/pnas.80.13.4124
Bilheimer, 1983, Trans Assoc Am Physicians, 96, 1
Grundy, 1984, Proc Natl Acad Sci USA, 81, 2538, 10.1073/pnas.81.8.2538
Grundy, 1985, J Lipid Res, 26, 1464, 10.1016/S0022-2275(20)34252-8
Illingworth, 1984, J Clin Invest, 74, 1972, 10.1172/JCI111618
Illingworth, 1987, Am J Cardiol, 60, 33G, 10.1016/0002-9149(87)90589-3
Illingworth, 1987, Eur Heart J, 8, 103, 10.1093/eurheartj/8.suppl_E.103
The Lovastatin Study Group II, 1986, JAMA, 256, 2829, 10.1001/jama.1986.03380200067023
Havel, 1987, Ann Intern Med, 107, 609, 10.7326/0003-4819-107-5-609
Tobert, 1987, Circulation, 76, 534, 10.1161/01.CIR.76.3.534
Parker, 1984, J Clin Invest, 74, 795, 10.1172/JCI111495
Pappu, 1987, Clin Res, 35, 625A
Goldstein, 1979, Annu Rev Genet, 13, 259, 10.1146/annurev.ge.13.120179.001355
Brown, 1986, Science, 232, 34, 10.1126/science.3513311
Goldstein, 1977, Annu Rev Biochem, 46, 897, 10.1146/annurev.bi.46.070177.004341
Ma, 1986, Proc Natl Acad Sci USA, 83, 8370, 10.1073/pnas.83.21.8370
Brown, 1983, J Clin Invest, 72, 743, 10.1172/JCI111044
Spady, 1983, Proc Natl Acad Sci USA, 80, 3499, 10.1073/pnas.80.11.3499
Bilheimer, 1984, N Engl J Med, 311, 1658, 10.1056/NEJM198412273112603
Kesaniemi, 1983, J Clin Invest, 71, 950, 10.1172/JCI110849
Olsson, 1986, Lancet, 2, 390, 10.1016/S0140-6736(86)90070-X
Mol, 1986, Lancet, 2, 936, 10.1016/S0140-6736(86)90598-2
Nakaya, 1987, JAMA, 257, 3088, 10.1001/jama.1987.03390220086026
Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:672–713.
1982, Med Clin North Am, 66, 335, 10.1016/S0025-7125(16)31424-9
Mabuchi, 1983, N Engl J Med, 308, 609, 10.1056/NEJM198303173081101
Illingworth, 1984, Ann Intern Med, 101, 598, 10.7326/0003-4819-101-5-598
Grundy, 1985, Ann Intern Med, 103, 339, 10.7326/0003-4819-103-3-339
Stamler, 1986, JAMA, 256, 2823, 10.1001/jama.1986.03380200061022
Vega, 1987, Am Heart J, 113, 493, 10.1016/0002-8703(87)90620-X
Hoeg, 1986, Am J Cardiol, 57, 933, 10.1016/0002-9149(86)90733-2
Ginsberg, 1987, J Clin Invest, 80, 1692, 10.1172/JCI113259
Thompson, 1986, Q J Med, 60, 803
Laue, 1987, J Clin Endocrinol Metab, 64, 531, 10.1210/jcem-64-3-531
Havel, 1982, Med Clin North Am, 66, 441, 10.1016/S0025-7125(16)31429-8
Weisgraber, 1981, J Biol Chem, 256, 9077, 10.1016/S0021-9258(19)52510-8
Grundy, 1984, J Lipid Res, 25, 1611, 10.1016/S0022-2275(20)34439-4
East, 1986, Metabolism, 35, 97, 10.1016/0026-0495(86)90106-X
Vega, 1988, Atherosclerosis, 70, 131, 10.1016/0021-9150(88)90107-4
Yoshino, 1986, Diabetes Res Clin Pract, 2, 179, 10.1016/S0168-8227(86)80020-1
Garg, 1988, N Engl J Med, 318, 81, 10.1056/NEJM198801143180204
Berlyne, 1969, Lancet, 2, 399, 10.1016/S0140-6736(69)90110-X
Vega, 1988, Kidney Int, 33, 1160, 10.1038/ki.1988.125
Goldstein, 1973, J Clin Invest, 52, 1533, 10.1172/JCI107331
Goldstein, 1973, J Clin Invest, 52, 1544, 10.1172/JCI107332
Grundy, 1987, Arteriosclerosis, 7, 203
Teng, 1986, J Clin Invest, 77, 663, 10.1172/JCI112360
Chait, 1980, Eur J Clin Invest, 10, 17, 10.1111/j.1365-2362.1980.tb00004.x
Janus, 1980, Eur J Clin Invest, 10, 161, 10.1111/j.1365-2362.1980.tb02076.x
Kissebah, 1981, Metabolism, 30, 856, 10.1016/0026-0495(81)90064-0
Arad, 1987, Clin Res, 35, 496A
Tobert, 1988, N Engl J Med, 318, 48, 10.1056/NEJM198801073180112
Mevacor (Lovastatin, MSD). United States Food and Drug Administration package insert. West Point, Pa.: Merck and Company.
Norman, 1988, N Engl J Med, 318, 46, 10.1056/NEJM198801073180110
East, 1988, N Engl J Med, 318, 47, 10.1056/NEJM198801073180111
Illingworth, 1985, Proc Natl Acad Sci USA, 82, 6291, 10.1073/pnas.82.18.6291
Famsworth, 1987, J Clin Endocrinol Metab, 65, 546, 10.1210/jcem-65-3-546
Duane WC, Hunninghake DB, Freeman ML, et al. Simvastatin: a competitive inhibitor of HMG CoA-reductase, lowers cholesterol saturation index of gallbladder bile. Hepatology (in press).
Tobert, 1987, Circulation, 76, 534, 10.1161/01.CIR.76.3.534
Hunninghake, 1988, JAMA, 259, 354, 10.1001/jama.1988.03720030022020
Hoffman, 1986, J Med Chem, 29, 849, 10.1021/jm00155a040
Nakaya, 1987, JAMA, 257, 3088, 10.1001/jama.1987.03390220086026
Illingworth, 1986, Clin Pharmacol Ther, 40, 338, 10.1038/clpt.1986.185
Lees, 1986, Arteriosclerosis, 6, 544A
Witztum, 1987, Am Heart J, 113, 603, 10.1016/0002-8703(87)90640-5
Vega, 1987, JAMA, 257, 33, 10.1001/jama.1987.03390010037024
